# Lymphoma
Who / What
Lymphoma is a **hematologic cancer** characterized by the abnormal growth of lymphocytes—white blood cells involved in immune function. It primarily affects the lymphatic system, leading to tumors that can develop in lymph nodes, spleen, bone marrow, or other organs.
---
Background & History
While lymphoma itself is not an organization but rather a medical condition, it has been studied extensively since its early recognition as a distinct cancer type. Historical milestones include the identification of Hodgkin’s lymphoma by **Sir Thomas Addison** in 1832 and later advancements in understanding non-Hodgkin lymphomas (NHL) through research in the mid-20th century. Key breakthroughs included the development of chemotherapy, radiotherapy, and targeted therapies, significantly improving patient outcomes.
---
Why Notable
Lymphoma remains a critical area of medical research due to its diverse subtypes, varying prognoses, and evolving treatment paradigms. Its study has contributed to broader cancer research, including insights into immune system dysfunction and genetic mutations. The condition’s impact on public health underscores the importance of early detection, personalized medicine, and global collaboration in oncology.
---
In the News
Recent advancements in lymphoma treatment—such as CAR-T cell therapy and immunotherapies—have renewed focus on this disease. Ongoing clinical trials aim to refine targeted therapies for rare subtypes, while awareness campaigns highlight its prevalence (e.g., NHL accounts for ~80% of lymphomas). The condition’s evolving landscape continues to drive research into biomarkers and precision oncology.
---
Key Facts
---
Links
[Wikipedia](https://en.wikipedia.org/wiki/Lymphoma)
